logo
Morgan Stanley recalibrates its view on Apple stock ahead of earnings

Morgan Stanley recalibrates its view on Apple stock ahead of earnings

Yahoo10 hours ago
Morgan Stanley recalibrates its view on Apple stock ahead of earnings originally appeared on TheStreet.
Apple's () financial engine fires on more than just iPhones; of late, we've seen one high-margin segment punching above its weight.
As it heads into its next earnings report, that trend could matter much more than expected.
💵💰💰💵
Also, if you follow the models, one firm's quiet recalibration might be the telltale sign of what's to come for Apple stock.
Sometimes, it's the side businesses that steal the show.
Apple's record quarter comes with a side of caution
Apple opened fiscal 2025 with a couple of powerful beats, which surprisingly attracted a muted response from Wall Street.
In the December quarter (Q1 2025), Apple posted all-time high sales of $124.3 billion, up 4% from a year ago, while delivering a $2.40 diluted EPS, representing a 10% jump.
The March quarter (Q2 2025) then kept up that momentum, with $95.4 billion in sales, representing 5% growth year-over-year and a record $1.65 EPS for the period.
The iPhone 16 was a smashing success, pushing iPhone revenue up 2% to $46.8 billion. Macs and iPads surprised, climbing 7% and 15%, respectively.However, it was Apple's Services segment that stole the show again, which is up 12% to $26.6 billion, thanks to App Store strength, Apple Music, and cloud offerings. Gross margins held near firm 47%, giving Apple a healthy cushion.
Still, Tim Cook isn't ignoring the risks.
He said that potential U.S. tariffs could shave up to $900 million off quarterly profit. In response, Apple's been ramping up iPhone assembly in India and Vietnam to efficiently spread out its supply chain risk.
It's also embracing AI with open arms.
Over the holidays, it rolled out 'Apple Intelligence,' layering in generative features into iOS, such as smarter Siri prompts and AI-edited photos.
Nonetheless, a pending antitrust ruling could force App Store changes that significantly impact in-app revenues.
More Stock News:
Top economist drops 6-word verdict on Trump tariffs, inflation
JPMorgan reveals 9 stocks with major problems
Bank of America quietly reboots Microsoft stock price target
That said, in reassuring its investors, Apple announced a whopping $100 billion buyback and raised its dividend to 26 cents per share.
Nevertheless, the stock is still down about 15% year to date.
Apple stock gets a boost from App Store surprise
Ahead of its Q3 earnings report in a few days, Apple just got a jolt from a familiar cash cow in the App Store.
According to Morgan Stanley, App Store sales in the U.S. surged 12.5% year-over-year through the first 20 days of July. That's a healthy increase from June's 11.5% gain, and shows no signs of slowing at this point.
What's remarkable is that it comes even after the recent Epic Games v. Apple ruling, which many feared could dent monetization.
Globally, App Store performance is just as encouraging. Revenue is up 7.1% year-over-year in China and 21% across other international markets, despite a relatively small 1.9% dip in Japan
If the quarter ended today, Morgan Stanley forecasts App Store revenue would be pacing at 12.6% growth, significantly more than the previous 11%.
That difference matters.
Based on current trends, Morgan Stanley forecasts $160 million in potential upside to Apple's September-quarter Services segment.
Additionally, Morgan Stanley analyst Erik Woodring says the monetization fears over Apple in terms of its apps business, post-lawsuit, are mostly overblown.
'After more than two months since the Apple vs. Epic injunction, we still have not seen meaningful impact on Apple's ability to monetize the U.S. App Store, despite the link-out risk,' he wrote.
With investors laser-focused on Apple's high-margin Services revenue, the App Store's resilience could be the start of something big for the tech giant.
It also underscores the company's growing dependence on recurring digital income at a time when iPhone upgrade cycles remain stretched.
Nonetheless, Apple is set to report Q3 results next week, and Wall Street expects earnings per share of $1.43 on $88.89 billion in revenue.
If App Store momentum holds, these estimates will likely appear much more conservative.Morgan Stanley recalibrates its view on Apple stock ahead of earnings first appeared on TheStreet on Jul 22, 2025
This story was originally reported by TheStreet on Jul 22, 2025, where it first appeared.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Thermo Fisher beats quarterly estimates on resilient demand for its tools and services
Thermo Fisher beats quarterly estimates on resilient demand for its tools and services

Yahoo

time24 minutes ago

  • Yahoo

Thermo Fisher beats quarterly estimates on resilient demand for its tools and services

(Reuters) -Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies. Shares of the medical equipment maker were up 2.5% in premarket trading. The company joins peers such as Danaher in beating quarterly profit estimates, citing strong demand from the industry for tools and services used to make vaccines and therapies. Danaher said on Tuesday it is seeing a robust number of clinical trials and therapies under development, with steady demand from its pharmaceutical clients. On an adjusted basis, Thermo Fisher reported a profit of $5.36 per share for the quarter ended June 28, beating analysts' estimate of $5.22 per share, as per data compiled by LSEG. The company said its business strategy called "practical process improvement" is helping adjust its supply chains in the tariff environment and to actively manage its cost base. Last week, the company said it will buy French drugmaker Sanofi's New Jersey manufacturing site, "to meet growing demand from pharma and biotech customers." The Waltham Massachusetts-based company's quarterly revenue rose 3% to $10.85 billion, compared to analyst estimates of $10.68 billion. Sales at its laboratory products segment, which makes up more than half of Thermo Fisher's total sales came in at $6 billion, above estimates of $5.79 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues
Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues

Yahoo

time24 minutes ago

  • Yahoo

Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues

(Reuters) -Shares of some highly-shorted companies, including Krispy Kreme and GoPro, jumped in premarket trading on Wednesday, aided by their names trending on social media forums a day after retail traders piled into department store company Kohl's. Doughnut chain Krispy Kreme jumped 16.1%, building on a near 27% surge on Tuesday. About 14% of Krispy Kreme's outstanding shares available for trading are shorted, according to data compiled by LSEG. Camera maker GoPro also surged about 47% to $2.01. Short interest on the stock was last at 7.7%. Another highly shorted stock - with short interest at 36.7% - was plant-based meat company Beyond Meat, whose shares jumped 10.4% on Wednesday. The growing interest in heavily shorted stocks comes after Kohl's surged 37.6% higher in volatile trading on Tuesday on the back of high retail interest. Mom-and-pop traders bought $9.64 million of its shares that day, the most by this category of investors in about three years, according to data from Vanda Research. Kohl's was flat in premarket trading on Wednesday but is the third most trending ticker on Stocktwits, a retail investor-focused social media platform. Among other highly shorted names, online gifts retailer rose 8.1%. Opendoor Technologies, which has rocketed 440% so far this month, was down 2.6% on Wednesday.

Thermo Fisher shares climb as Q2 top and bottom line exceed estimates
Thermo Fisher shares climb as Q2 top and bottom line exceed estimates

Yahoo

time24 minutes ago

  • Yahoo

Thermo Fisher shares climb as Q2 top and bottom line exceed estimates

-- Thermo Fisher Scientific Inc (NYSE:TMO) reported second-quarter earnings that topped expectations, with revenue also coming in ahead of forecasts. The company reported adjusted EPS of $5.36, beating the analyst estimate of $5.23. Revenue rose 3% from a year earlier to $10.85 billion, above the $10.68 billion consensus. Shares in the medical equipment maker were up 2.3% in premarket trading Wednesday as of 06:06 ET. 'Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment," said Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific. Adjusted operating income reached $2.38 billion, slightly up from $2.35 billion in the same period last year. Adjusted operating margin slipped to 21.9% from 22.3% a year ago. Related articles Thermo Fisher shares climb as Q2 top and bottom line exceed estimates These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia If Powell goes, does Fed trust go with him?

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store